“Schizophrenia is not only a disorder of hallucinations and delusions, but a disorder of living.
Even
when symptoms are controlled, many patients continue to struggle with poor social functioning,
reduced quality of life, and difficulty connecting with others.
Schizophrenia affects approximately one percent of the population and is considered one of
the most disabling mental illnesses worldwide. In the Indian context, studies suggest that the
burden of schizophrenia disproportionately affects individuals from lower socioeconomic
backgrounds, thereby increasing long-term caregiving and healthcare demands.
Although pharmacological treatment remains the cornerstone of management, its benefits are
largely confined to the reduction of positive symptoms such as hallucinations and delusions.
Emotional and functional recovery, however, remains limited. Negative symptoms—
including emotional blunting, avolition, and social withdrawal—often persist despite clinical
stability and significantly interfere with daily functioning.
Importantly, research indicates that quality of life remains poor even in clinically stable
patients. This highlights a critical limitation of existing interventions, which tend to prioritize
symptom reduction over psychosocial recovery. As a result, there is a growing recognition of
the need for complementary approaches that address emotional, social, and functional
outcomes alongside symptom management.
This gap between symptom control and real-life recovery brings us to the theoretical and clinical
rationale for the present study.”
Music represents a non-verbal and emotion-based form of intervention that can bypass many
of the cognitive and linguistic deficits commonly seen in schizophrenia. Because music
primarily engages emotional and affective systems, it offers a unique pathway to reach
patients who may struggle with verbal expression or abstract cognitive processing.
Empathy and Theory of Mind deficits are now recognized as core social-cognitive
impairments in schizophrenia. These deficits significantly affect interpersonal relationships,
social functioning, and overall quality of life, even when psychotic symptoms are clinically
controlled.
Evidence from systematic reviews suggests that music-based interventions can improve
emotional processing and social engagement in individuals. By engaging affective and social
brain networks, music provides a promising mechanism for addressing empathy-related
difficulties.
In the Indian context, Indian classical music holds particular relevance as a culturally familiar
and emotionally structured form of auditory stimulation. Within this tradition, Raag Yaman
is especially suitable for clinical application due to its tonal stability, moderate tempo,
predictable melodic progression, and low-arousal emotional profile. The raga is traditionally
associated with calmness and emotional balance rather than intense emotional excitation,
making it appropriate for individuals with schizophrenia. Its structured yet soothing melodic
framework allows for passive listening without demanding cognitive effort, thereby
supporting emotional regulation and social attunement. Given the need for low-cost,
culturally appropriate, and complementary interventions suitable for low-resource settings,
raga-based listening—specifically Raag Yaman—offers a theoretically sound and clinically
meaningful approach.
SLIDE 1 — WHAT IS KNOWN
(Speaker Script – concise & focused)
“From existing literature, several points are clearly established. Schizophrenia is associated
with persistent positive and negative symptoms that significantly impair functioning and
quality of life, even during periods of clinical stability. Research consistently shows that
quality of life is influenced more by negative symptoms and social functioning than by
positive symptoms alone.
Evidence from systematic reviews and meta-analyses indicates that music therapy, when used
as an adjunct to standard treatment, can reduce symptom severity, improve emotional
regulation, and enhance social functioning in schizophrenia.
Additionally, Indian Classical Music has been shown to influence emotional states, brain
activity, and autonomic functioning. EEG and psychophysiological studies demonstrate
relaxation-related neural changes during raga listening. Preliminary clinical and meta-analytic
evidence further suggests that negative symptoms may be particularly responsive to music-
based interventions.”
🔵 SLIDE 2 — WHAT IS NOT KNOWN / RESEARCH
GAPS
(Speaker Script – gap-focused, no repetition)
“However, despite these findings, significant gaps remain. There are very limited systematic
studies examining Indian Classical Music specifically as a complementary intervention in
schizophrenia. Most available evidence comes from Western music therapy models or
heterogeneous musical interventions.
There is also a clear scarcity of evidence on how Indian Classical Music affects positive
symptoms and empathy, despite empathy being a well-established social cognitive deficit in
schizophrenia.
Furthermore, culturally grounded and region-specific data from Indian psychiatric settings
are limited, with much of the existing Indian research being institution-based or unpublished.
Importantly, no controlled studies have examined whether raga-based interventions—
particularly Raga Yaman—can influence empathy, quality of life, or symptom severity in
schizophrenia.”
(Pause → this sets up your study)
SLIDE 3 — WHY THIS RESEARCH IS NEEDED
(Speaker Script – confident & forward-looking)
“These gaps highlight the need for the present study. There is a clear requirement for
culturally relevant, non-pharmacological interventions that can complement medication-
based treatment in schizophrenia.
Generating empirical evidence on Indian Classical Music allows us to evaluate its effects not
only on symptoms, but also on recovery-oriented outcomes such as empathy and quality of
life, which remain under-addressed.
Finally, producing systematic data from an Indian clinical context can help inform
rehabilitation programs and psychosocial interventions in psychiatric settings, supporting the
integration of culturally acceptable and low-risk approaches into routine clinical practice.”
🔵 SLIDE: Study Design & Setting
(Speaker Script – concise & precise)
“The study follows a pretest–posttest experimental design with two groups: an experimental
group receiving the music intervention and a control group receiving treatment as usual. This
design allows comparison of changes over time while controlling for the effects of routine
clinical care.
The study will be conducted in the Department of Clinical Psychology at the Central Institute
of Psychiatry, Ranchi, which provides a stable clinical setting with ongoing psychiatric
treatment and rehabilitation services. Conducting the study in this setting ensures diagnostic
reliability, clinical supervision, and standardized assessment procedures.”
🔵 SLIDE: Population & Sampling
(Speaker Script – concise)
“The study population consists of adult patients diagnosed with schizophrenia who are
attending inpatient services. Participants will be selected using purposive sampling to ensure
that they meet the diagnostic and clinical stability criteria required for the study.
Following selection, participants will be randomly allocated to either the experimental or
control group. This approach allows for both clinical appropriateness in participant selection
and reduction of allocation bias. The final sample size will be 28 participants, with 14
participants in each group.”
🔵 SLIDE: Population, Sampling & Sample Size
(Speaker Script – short and clear)
“The study population comprises adult patients diagnosed with schizophrenia who are
attending inpatient services. Participants will be selected using purposive sampling to ensure
that only individuals meeting the diagnostic and clinical stability criteria are included.
After selection, participants will be randomly allocated to either the experimental or control
group in order to reduce allocation bias and ensure comparability between groups. The total
sample size for the study is 28 participants, with 14 participants in each group.”
SLIDE: Procedure
(Speaker Script – clear & sequential)
“The procedure begins with patient recruitment from inpatient services. Diagnosis of
schizophrenia will be confirmed using ICD-10 criteria to ensure diagnostic accuracy.
Eligible patients will then be screened using predefined inclusion and exclusion criteria.
Those meeting criteria will be provided detailed information about the study, and written
informed consent will be obtained prior to participation.
Following consent, baseline assessment will be conducted. This includes assessment of
symptom severity using PANSS, empathy using the Interpersonal Reactivity Index, and
quality of life using the WHO Quality of Life scale.
Participants will then be randomly allocated into either the experimental group or the control
group. The experimental group will receive a passive listening intervention consisting of
Raag Yaman for 12 sessions over a period of four weeks, with sessions lasting approximately
30 to 40 minutes. The control group will continue to receive treatment as usual.
A mid-intervention assessment will be conducted at the end of the second week using the
same assessment tools to monitor interim changes.
Finally, post-intervention assessment will be carried out at the end of four weeks using
PANSS, empathy, and quality of life measures to evaluate the overall effect of the
intervention.”
SLIDE: Statistical Analysis
(Speaker Script – concise)
“Data will be analyzed using SPSS. Descriptive statistics, including mean, standard
deviation, frequencies, and percentages, will be used to summarize the sample characteristics
and baseline scores.
Prior to inferential analysis, normality of the data will be assessed to determine the suitability
of parametric tests.
Between-group comparisons will be conducted using independent samples t-tests to examine
differences between the experimental and control groups. Within-group changes from pre- to
post-intervention will be analyzed using paired samples t-tests.
Additional statistical analyses, if required, will be selected based on the distribution of the
data and study outcomes after data collection.”
SLIDE: Ethical Considerations
(Speaker Script – concise)
“Ethical safeguards will be strictly followed throughout the study. Written informed consent
will be obtained from all participants, and from caregivers wherever required, after providing
complete information about the study.
Confidentiality of participant data will be maintained, and all records will be used solely for
research purposes.
The study protocol has been reviewed and approved by the Institute Ethics Committee of the
Central Institute of Psychiatry, Ranchi.
Participation will be entirely voluntary, and participants will retain the right to withdraw from
the study at any stage without any adverse consequences.”
🔵 SLIDE: Feasibility
(Speaker Script – concise)
“The study is feasible within the existing clinical setup. Recruitment will be carried out
through both outpatient and inpatient services at the Central Institute of Psychiatry, ensuring
adequate participant availability.
The intervention involves non-invasive, passive listening, which requires minimal effort from
participants and does not interfere with ongoing treatment.
Assessment sessions are brief and structured, making them manageable within routine
clinical schedules. The study does not impose any additional financial burden on participants.
Importantly, the intervention will be conducted alongside standard psychiatric care, ensuring
clinical safety and continuity of treatment.”
🗣️ SCRIPT – WHAT YOU SAY FOR SLIDE 1
Schizophrenia is a severe mental illness affecting about one percent of the population
worldwide, across cultures and genders. Although men and women are affected equally, the
onset and course differ, and the illness places a substantial burden not only on patients but
also on families and healthcare systems.
Clinically, schizophrenia is characterised by positive symptoms such as hallucinations and
delusions, and negative symptoms such as reduced emotional expression, lack of motivation,
anhedonia, and social withdrawal. While antipsychotic medications are effective in
controlling positive symptoms, they are far less effective for negative symptoms and often
produce significant physical side effects, including weight gain, metabolic disturbances, and
cardiovascular risk. Importantly, even when patients are clinically stable, studies consistently
show that their quality of life remains markedly impaired.
Large, highly cited reviews have demonstrated that symptom reduction alone does not equate
to recovery. Research by Green and colleagues, and later by Fett et al., clearly established
that social cognition deficits are stronger predictors of real-world functioning and quality of
life than symptom severity itself. Among these social cognitive deficits, empathy plays a
particularly important role because it directly influences interpersonal relationships, social
engagement, and community functioning. This highlights a critical gap in current treatment
approaches that focus primarily on symptom control rather than functional and emotional
recovery
